AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30921982 — intervention group
Group type: COMPARATOR
Intervention: Th1/2-parasagittal interlaminar epidural injection (Th1/2-pILEI)
Number of subjects: 30
Study 28412762 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration (<6.0 h)
Number of subjects: 981
Study 28412762 — intervention group
Group type: EXPERIMENTAL
Intervention: Late bedtime (C1 vs. A1 and C2 vs. A2 or B2)
Number of subjects: 981
Study 25843539 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60
Study 25843539 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 60
Study 23499567 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle warm-up (IMW)
Number of subjects: 10
Study 23499567 — intervention group
Group type: COMPARATOR
Intervention: Placebo (IMWP)
Number of subjects: 10
Study 23499567 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 10
Study 22221427 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms and Beclomethasone 200 micrograms (HFA; metered-dose inhaler) b.i.d. (FB)
Number of subjects: 10
Study 22221427 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 micrograms and Fluticasone 250 micrograms (dry-powder inhaler) b.i.d. (SF)
Number of subjects: 10
Study 19224761 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (6MP)/methotrexate (MTX) maintenance therapy
Number of subjects: 1614
Study 19224761 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of oral 6MP/MTX maintenance therapy
Number of subjects: 1614
Study 19224761 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of high hyperdiploidy
Number of subjects: 1614
Study 19224761 — intervention group
Group type: EXPERIMENTAL
Intervention: TPMT activity measured in patients
Number of subjects: 1614
Study 19224761 — intervention group
Group type: EXPERIMENTAL
Intervention: Average 6MP doses in TPMT wild-type patients
Number of subjects: 1614
Study 17301297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone, 30 mg per kilogram of body weight
Number of subjects: 199
Study 17301297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 16265829 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (oral and intravenous fluid replacement, NSAIDs, caffeine)
Number of subjects: 32
Study 16265829 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural blood patch (EBP)
Number of subjects: 32
Study 11591613 — intervention group
Group type: COMPARATOR
Intervention: CEE 0.625 mg
Number of subjects: 45
Study 11591613 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg and MPA 2.5 mg
Number of subjects: 45
Study 11591613 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg and MPA 5.0 mg
Number of subjects: 45
Study 11591613 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 9574878 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 microg b.i.d.; n = 16)
Number of subjects: 44
Study 9574878 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine (200 microg b.i.d.; n = 16)
Number of subjects: 44
Study 9574878 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 44
Study 7875113 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 9
Study 7875113 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral electroconvulsive therapy (ECT)
Number of subjects: 9
Study 3213920 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia plus retrobulbar block
Number of subjects: 28
Study 3213920 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia alone
Number of subjects: 28
Study 29850915 — intervention group
Group type: EXPERIMENTAL
Intervention: disease-specific manualized CBT (PASCET-PI) plus standard medical care (CAU)
Number of subjects: 70
Study 29850915 — intervention group
Group type: COMPARATOR
Intervention: standard medical care (CAU)
Number of subjects: 70
Study 26530153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation with nocturnal light exposure
Number of subjects: 0
Study 26530153 — intervention group
Group type: COMPARATOR
Intervention: Sleep deprivation under dark conditions
Number of subjects: 0
Study 24838360 — intervention group
Group type: EXPERIMENTAL
Intervention: Long detection setting (30 of 40 intervals)
Number of subjects: 477
Study 24838360 — intervention group
Group type: COMPARATOR
Intervention: Nominal setting (18 of 24 intervals)
Number of subjects: 477
Study 23564755 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 16496
Study 23564755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16496
Study 19783808 — intervention group
Group type: EXPERIMENTAL
Intervention: High behavior modification
Number of subjects: 0
Study 19783808 — intervention group
Group type: COMPARATOR
Intervention: Low behavior modification
Number of subjects: 0
Study 19783808 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication manipulation
Number of subjects: 0
Study 18684808 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 84
Study 18684808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 16140028 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) inhalation (3 ml 0.1% in PBS)
Number of subjects: 16
Study 16140028 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation (3 ml PBS)
Number of subjects: 16
Study 16140028 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) inhalation
Number of subjects: 16
Study 16140028 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 16
Study 12777432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Number of subjects: 1000
Study 12777432 — intervention group
Group type: COMPARATOR
Intervention: Post-mortem questionnaire
Number of subjects: 1000
Study 12777432 — intervention group
Group type: COMPARATOR
Intervention: All-cause mortality
Number of subjects: 1000
Study 11404653 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol by Diskus
Number of subjects: 27
Study 11404653 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol by pMDI
Number of subjects: 27
Study 11404653 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study 11404653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 9363868 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL‐11 (50 microg/kg/d)
Number of subjects: 77
Study 9363868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 9363868 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL‐11
Number of subjects: 77
Study 1306735 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg 4-HPR daily for 52 weeks
Number of subjects: 115
Study 1306735 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 115
Study 2986901 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril therapy
Number of subjects: 12
Study 2986901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31970796 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood treatment
Number of subjects: 15
Study 31970796 — intervention group
Group type: COMPARATOR
Intervention: Component therapy (current standard of care)
Number of subjects: 15
Study 31970796 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative risk of whole blood compared to component therapy
Number of subjects: 15
Study 30663629 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient individual treatment adherence
Number of subjects: 0
Study 30663629 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized admission assessment with the European Addiction Severity Index (EuropASI)
Number of subjects: 0
Study 29265999 — intervention group
Group type: EXPERIMENTAL
Intervention: Mam-Kind intervention
Number of subjects: 70
Study 26190381 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol handrub (covering all hand surfaces in no particular order)
Number of subjects: 0
Study 26190381 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol handrub (using the 7-step technique)
Number of subjects: 0
Study 26190381 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine handwashing
Number of subjects: 0
Study 23318877 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 16 weeks
Number of subjects: 11
Study 23318877 — intervention group
Group type: COMPARATOR
Intervention: Women with PCOS
Number of subjects: 11
Study 20835747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (blood pressure levels)
Number of subjects: 82037
Study 20835747 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 82037
Study 20021654 — intervention group
Group type: EXPERIMENTAL
Intervention: IUI COH (Intrauterine Insemination with Controlled Ovarian Hyperstimulation)
Number of subjects: 600
Study 20021654 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF e SET (IVF elective Single Embryo Transfer)
Number of subjects: 600
Study 20021654 — intervention group
Group type: EXPERIMENTAL
Intervention: MNC IVF (Modified Natural Cycle IVF)
Number of subjects: 600
Study 20021654 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 600
Study 16754834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (100 ng/mL of plasma)
Number of subjects: 15
Study 16754834 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ketamine (200 ng/mL of plasma)
Number of subjects: 15
Study 16754834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 12887574 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Triad VLC resin
Number of subjects: 35
Study 12887574 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT resin
Number of subjects: 35
Study 10501150 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous and all-night exposure to noise at 45 dBA
Number of subjects: 0
Study 10501150 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent noise exposure
Number of subjects: 0
Study 10501150 — intervention group
Group type: COMPARATOR
Intervention: Silent environment
Number of subjects: 0
Study 9198430 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Retroplast with ytterbium trifluoride
Number of subjects: 351
Study 9198430 — intervention group
Group type: COMPARATOR
Intervention: Silver-containing Retroplast
Number of subjects: 351
Study 1672841 — intervention group
Group type: EXPERIMENTAL
Intervention: Antianginal drugs (beta-blockers, calcium antagonists, nitrates, alone or in various combinations)
Number of subjects: 57
Study 7031853 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 0
Study 7031853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6439699 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed beam radiation therapy
Number of subjects: 322
Study 6439699 — intervention group
Group type: COMPARATOR
Intervention: Photon radiation therapy
Number of subjects: 322
Study 29714435 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol
Number of subjects: 50
Study 29714435 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 50
Study 28033254 — intervention group
Group type: EXPERIMENTAL
Intervention: Early home-based cardiac rehabilitation program
Number of subjects: 52
Study 28033254 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 52
Study 25117997 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU D2 from UVB-treated mushrooms
Number of subjects: 43
Study 25117997 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU D2 from UVB-treated mushrooms
Number of subjects: 43
Study 25117997 — intervention group
Group type: COMPARATOR
Intervention: 600 IU D3 from untreated mushrooms
Number of subjects: 43
Study 25117997 — intervention group
Group type: COMPARATOR
Intervention: 4000 IU D3 from untreated mushrooms
Number of subjects: 43
Study 22772335 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine D₃ receptor antagonist, GSK598809 (175 mg)
Number of subjects: 26
Study 22772335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 20046182 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluorodeoxyglucose (FDG) PET imaging during exercise
Number of subjects: 0
Study 18330846 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) monotherapy, mean maintenance dose 217.2 mg/day
Number of subjects: 446
Study 18330846 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) monotherapy
Number of subjects: 446
Study 15983308 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST) for approximately 6 months
Number of subjects: 127
Study 15983308 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 127
Study 15983308 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 127
Study 12671340 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable defibrillators
Number of subjects: 0
Study 12671340 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone and dofetilide
Number of subjects: 0
Study 10408847 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg intravenous
Number of subjects: 223
Study 10408847 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 25 mg oral plus metopimazine 30 mg oral
Number of subjects: 223
Study 8877895 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (15 mg) after meal A (8.8 g fat)
Number of subjects: 18
Study 8877895 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (15 mg) after meal B (20.0 g fat)
Number of subjects: 18
Study 8877895 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (15 mg) after meal C (34.9 g fat)
Number of subjects: 18
Study 8877895 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (15 mg) after meal B (20.0 g fat) without lunch
Number of subjects: 18
Study 8877895 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (15 mg) after meal D (53.8 g fat)
Number of subjects: 18
Study 1892404 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotics from immediately after surgery until the third day (Group B)
Number of subjects: 2165
Study 1892404 — intervention group
Group type: EXPERIMENTAL
Intervention: Local sterile antibiotic powder sprinkled into the wound during surgery (Group C)
Number of subjects: 2165
Study 1892404 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotics from 2 days before surgery until the second day after surgery (Group D)
Number of subjects: 2165
Study 1892404 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (Group A)
Number of subjects: 2165
Study 6135828 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion diets and double-blind food provocation
Number of subjects: 27
Study 6135828 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent psychiatric examination
Number of subjects: 27
Study 30866108 — intervention group
Group type: EXPERIMENTAL
Intervention: Detomidine (0.01 mg/kg bwt)
Number of subjects: 6
Study 30866108 — intervention group
Group type: EXPERIMENTAL
Intervention: Detomidine (0.01 mg/kg bwt) + Butorphanol (0.02 mg/kg bwt)
Number of subjects: 6
Study 30866108 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% solution, 10 mL)
Number of subjects: 6
Study 28604151 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem-Hydrochloride (DTZ) in sustained-release matrix tablets
Number of subjects: 8
Study 28604151 — intervention group
Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 8
Study 27214088 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan (3 and 10 μg/kg/min for 15 min per dose)
Number of subjects: 73
Study 27214088 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan (3 and 10 μg/kg/min for 15 min per dose) with low sodium diet
Number of subjects: 73
Study 27214088 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan (3 and 10 μg/kg/min for 15 min per dose) with Ang II co-infusion (1 ng/kg/min)
Number of subjects: 73
Study 25075176 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (5 mL) delivered by JetPeel™‐3 followed by multiple injections of BTX‐A (100 units)
Number of subjects: 20
Study 25075176 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (5 mL) and BTX‐A (50 units) delivered together by JetPeel™‐3
Number of subjects: 20
Study 25075176 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine delivered by JetPeel™‐3 followed by multiple BTX‐A injections
Number of subjects: 20
Study 22748624 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiomersal-containing process (Group TC)
Number of subjects: 320
Study 22748624 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiomersal-free process (Group TF)
Number of subjects: 320
Study 20185655 — intervention group
Group type: EXPERIMENTAL
Intervention: CARDEAN
Number of subjects: 159
Study 20185655 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 159
Study 18035201 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (400 mg daily, titrated over 8 weeks)
Number of subjects: 12
Study 18035201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16282256 — intervention group
Group type: EXPERIMENTAL
Intervention: START program (short-term acute residential treatment)
Number of subjects: 99
Study 16282256 — intervention group
Group type: COMPARATOR
Intervention: Inpatient unit at a Department of Veterans Affairs (VA) hospital
Number of subjects: 99
Study 12580657 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 18
Study 12580657 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plyometric training)
Number of subjects: 18
Study 10070128 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin 5 ng. kg‐1. min‐1
Number of subjects: 8
Study 10070128 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin 10 ng. kg‐1. min‐1
Number of subjects: 8
Study 10070128 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin 20 ng. kg‐1. min‐1
Number of subjects: 8
Study 10070128 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin 40 ng. kg‐1. min‐1
Number of subjects: 8
Study 7718463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% ketoconazole shampoo (twice weekly for 2-4 weeks)
Number of subjects: 575
Study 7718463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% ketoconazole shampoo (once-weekly, once every other week, alternating with placebo)
Number of subjects: 575
Study 7718463 — intervention group
Group type: COMPARATOR
Intervention: Placebo shampoo (once-weekly)
Number of subjects: 575
Study 7718463 — intervention group
Group type: EXPERIMENTAL
Intervention: Active/placebo group (alternating treatment)
Number of subjects: 575
Study 2044721 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonyl iron
Number of subjects: 49
Study 2044721 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate
Number of subjects: 49
Study 6112386 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid plus dipyridamole (1050 mg + 150 mg/day, group A)
Number of subjects: 66
Study 6112386 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg/day, group B)
Number of subjects: 66
Study 6112386 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study 31390223 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathway (CP) implemented in 31 teams
Number of subjects: 56
Study 31390223 — intervention group
Group type: COMPARATOR
Intervention: Usual care in 25 teams
Number of subjects: 56
Study 28006059 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab with radiotherapy and cisplatin
Number of subjects: 891
Study 26338693 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (5‐30 mg/d)
Number of subjects: 198
Study 26338693 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (1‐6 mg/d)
Number of subjects: 198
Study 26338693 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 198
Study 26338693 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 198
Study 23672956 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous hydrocortisone (100 mg)
Number of subjects: 12
Study 23672956 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular hydrocortisone (100 mg)
Number of subjects: 12
Study 23672956 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (0.9%)
Number of subjects: 12
Study 21904103 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-FV group (behavioral intervention with meal replacements, fruits, and vegetables)
Number of subjects: 38
Study 21904103 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual-care weight-loss counseling)
Number of subjects: 38
Study 19434784 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical provocation with 15 mg GSTS
Number of subjects: 24
Study 19434784 — intervention group
Group type: COMPARATOR
Intervention: Control provocation
Number of subjects: 24
Study 16753016 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 or 40 microg
Number of subjects: 55
Study 16753016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 15107771 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay autogenous bone graft from the mandibular/chin area
Number of subjects: 20
Study 10770199 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate
Number of subjects: 21
Study 10770199 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 21
Study 10770199 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate
Number of subjects: 21
Study 10770199 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 21
Study 10770199 — intervention group
Group type: EXPERIMENTAL
Intervention: L-[3-13C1]sodium lactate and D-[6,6-D2]glucose infusion
Number of subjects: 21
Study 10770199 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 21
Study 9354211 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pentazocine i.v.
Number of subjects: 20